Biocon Biologics ties-up with Sandoz Australia for cancer biosimilars

Sandoz will get the exclusive rights to promote, sell, and distribute Trastuzumab and Bevacizumab, which are used in the treatment of various cancers, in Australia

Related Keywords

Australia ,Japan ,Matt Erick ,National Stock Exchange ,Biocon Ltd ,Biocon Biologics Ltd ,Biocon ,Biologics Ltd ,Chief Commercial Officer ,Advanced Markets ,Sandoz Ag ,Harmaceutical Deal ,